Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Stocks - Europe Seen Higher; Vaccine News Helps

Published 07/15/2020, 02:04 AM
Updated 07/15/2020, 02:05 AM
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com - European stock markets are set to open higher Wednesday, with investors buoyed by optimism about a coronavirus vaccine as well as the chance a key EU summit will lead to more stimulus.

At 2:05 AM ET (0605 GMT), the DAX futures contract in Germany traded 0.7% higher, the FTSE 100 futures contract in the U.K. rose 1%, while CAC 40 futures in France gained 1.1%.

Helping the positive tone Wednesday was the news that the first Covid-19 vaccine tested in people has shown early promising results.

U.S. biotech firm Moderna 's  (NASDAQ:MRNA) experimental Covid-19 vaccine was declared safe and generated “robust” immune responses in all 45 volunteers taking part in the study, according to early-stage human trial results published in the New England Journal of Medicine on Tuesday.

“This does not mean that it may lead to a vaccine in the end, but it is an important step towards finding a vaccine,” said analysts at Danske Bank, in a research note.

.However, Japan’s capital Tokyo raised its warning level to the highest level, and three U.S. states reported new record daily deaths from the pandemic.

That said, there are hopes the European Union could agree at its summit later this week on a rescue financing package that will limit the economic damage to the bloc.

Additionally, the European Central Bank is set to meet Thursday, but isn't expexted to ease its policy any further this time.

In corporate news, Svenska Handelsbanken (ST:SHBa) posted a 6.1% drop in second-quarter net profit as lower interest rates dented income, but the profit decline was smaller than expected thanks to lower costs and a sharp fall in credit losses.

U.K. luxury group Burberry (LON:BRBY) said it expects sales for the six months through September to be down around 15%-20% from a year earlier, despite a solid recovery in demand since April.

TomTom (AS:TOM2) posted a net loss for the second quarter of 2020, but the Dutch navigational-technologies company added its operational revenue was on track to recover from the lows it experienced in April due to the coronavirus pandemic.

Oil prices pushed higher Wednesday, helped by a sharp fall in U.S. crude inventories of 8.3 million barrels in the week to July 10, according to data from industry group the American Petroleum Institute. Official numbers from the Energy Information Administration are due later Wednesday.

The so-called OPEC+ bloc is set to decide whether to extend output cuts of 9.7 million barrels per day that end in July or ease them to 7.7 million barrels per day.

At 2:05 AM ET, U.S. crude futures traded 0.5% higher at $40.48 a barrel, while the international benchmark Brent contract rose 0.3% to $43.03.

Elsewhere, gold futures fell 0.2% to $1,809.10/oz, while EUR/USD traded at 1.1401, up 0.1%.

 

Latest comments

good news!
fake news
Vaccine hopes? Is all you can say? Tomorro when stocks go down the head line will be what? I know “stock market down because corona virus fears” lol
yes it is.
Bingo. They literally check if the stock market is up or down and make up some *******to suit the trend. As you said market up=vaccine hope, market down=fear of coronavirus. Lazy reporting.
🤣🤣🤣🤣🤣
More trump  lies please!
More fake news please!!!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.